Home›People›Doug Reed
DR

Doug Reed

Director at Endogenex

Director
Updated Nov 8, 2026·Latest SEC filing Nov 6, 2026·Suggest an edit

About Doug Reed

Doug Reed is a director of Endogenex, which develops an investigational endoscopic system for people with type 2 diabetes.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Doug Reed in the role, so the role may have started earlier or lasted longer.

Endogenex, Inc. Current
Director
2026 – Present · Plymouth, MN
Endogenex develops an outpatient endoscopic system using pulsed electric fields to treat duodenal tissue in adults with type 2 diabetes.

Key Colleagues at Startups

The people Doug Reed works with at each company, as listed on that company's latest Form D.

Endogenex, Inc. · Form D/A, Nov 6, 2026
Stacey Pugh
Stacey Pugh
CEO and director
Juliet Bakker
Juliet Bakker
Co-Founder and Managing Director
GB
Gerald Brunk
Managing Director
JE
James Eadie
Managing Director
TS
Thomas Shehab
Managing Partner and director

Sources

  1. SECEndogenex, Inc. Form D/A, filed Nov 6, 2026
  2. P2Endogenex home page
  3. P3Avivomed team page
  4. P4Contego Medical leadership team